GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » Change In Receivables

Meta Biomed Co (XKRX:059210) Change In Receivables : ₩4,046 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co Change In Receivables?

Meta Biomed Co's change in receivables for the quarter that ended in Mar. 2024 was ₩1,081 Mil. It means Meta Biomed Co's Accounts Receivable declined by ₩1,081 Mil from Dec. 2023 to Mar. 2024 .

Meta Biomed Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩427 Mil. It means Meta Biomed Co's Accounts Receivable declined by ₩427 Mil from Dec. 2022 to Dec. 2023 .

Meta Biomed Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩13,089 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Meta Biomed Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 53.08.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Meta Biomed Co's liquidation value for the three months ended in Mar. 2024 was ₩-24,395 Mil.


Meta Biomed Co Change In Receivables Historical Data

The historical data trend for Meta Biomed Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meta Biomed Co Change In Receivables Chart

Meta Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,853.53 2,740.96 1,257.44 -1,635.00 427.35

Meta Biomed Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,538.24 988.12 1,848.29 129.17 1,080.57

Meta Biomed Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,046 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meta Biomed Co  (XKRX:059210) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Meta Biomed Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=13089.48/22502.545*91
=53.08

2. In Ben Graham's calculation of liquidation value, Meta Biomed Co's accounts receivable are only considered to be worth 75% of book value:

Meta Biomed Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=43009.985-85444.623+0.75 * 13089.48+0.5 * 16444.588
=-24,395

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meta Biomed Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co (XKRX:059210) Business Description

Traded in Other Exchanges
N/A
Address
634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines